These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 9430037)

  • 21. Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences.
    Tonon M; Piano S
    Med Clin North Am; 2023 May; 107(3):505-516. PubMed ID: 37001950
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [TIPS is a life-prolonging treatment of those cirrhosis patients with ascites who can not be treated medically or with paracentesis].
    Aalykke C; Tønner-Nielsen D; Vilstrup H
    Ugeskr Laeger; 2005 Oct; 167(44):4197; author reply 4198-9. PubMed ID: 16266584
    [No Abstract]   [Full Text] [Related]  

  • 23. Management of ascites in patients with chronic liver disease.
    Aiza I; Perez GO; Schiff ER
    Am J Gastroenterol; 1994 Nov; 89(11):1949-56. PubMed ID: 7942716
    [No Abstract]   [Full Text] [Related]  

  • 24. Refractory Ascites in Liver Cirrhosis.
    Adebayo D; Neong SF; Wong F
    Am J Gastroenterol; 2019 Jan; 114(1):40-47. PubMed ID: 29973706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of patients with cirrhosis and ascites.
    Runyon BA
    Semin Liver Dis; 1997; 17(3):249-60. PubMed ID: 9308129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of ascites and renal failure in cirrhosis.
    Forns X; Ginès A; Ginès P; Arroyo V
    Semin Liver Dis; 1994 Feb; 14(1):82-96. PubMed ID: 8016665
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS): a caution.
    Martinet JP; Fenyves D; Legault L; Roy L; Dufresne MP; Spahr L; Lafortune M; Pomier-Layrargues G
    Dig Dis Sci; 1997 Jan; 42(1):161-6. PubMed ID: 9009133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transjugular Intrahepatic Portosystemic Shunts With Covered Stents Increase Transplant-Free Survival of Patients With Cirrhosis and Recurrent Ascites.
    Bureau C; Thabut D; Oberti F; Dharancy S; Carbonell N; Bouvier A; Mathurin P; Otal P; Cabarrou P; Péron JM; Vinel JP
    Gastroenterology; 2017 Jan; 152(1):157-163. PubMed ID: 27663604
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of ascites in patients with cirrhosis. What to do when diuretics fail.
    Porayko MK; Wiesner RH
    Postgrad Med; 1992 Dec; 92(8):155-8, 161-6. PubMed ID: 1454665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of refractory ascites.
    Cárdenas A; Ginès P
    Clin Gastroenterol Hepatol; 2005 Dec; 3(12):1187-91. PubMed ID: 16361042
    [No Abstract]   [Full Text] [Related]  

  • 33. [Current status of treatment of refractory ascites in patients with liver cirrhosis].
    Shao J; Zhang L; Han GH; Fan DM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Oct; 24(10):721-723. PubMed ID: 27938554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TIPS for management of refractory ascites: response and survival are both unpredictable.
    Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
    Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnosis and treatment of ascites.
    Tsochatzis EA; Gerbes AL
    J Hepatol; 2017 Jul; 67(1):184-185. PubMed ID: 28119010
    [No Abstract]   [Full Text] [Related]  

  • 36. Automated low-flow ascites pump in a real-world setting: complications and outcomes.
    Solbach P; Höner Zu Siederdissen C; Wellhöner F; Richter N; Heidrich B; Lenzen H; Kerstin P; Hueper K; Manns MP; Wedemeyer H; Jaeckel E
    Eur J Gastroenterol Hepatol; 2018 Sep; 30(9):1082-1089. PubMed ID: 29738325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [How I treat ... ascites].
    Gielen S; Delwaide J; Detry O; Belaiche J;
    Rev Med Liege; 2001 Dec; 56(12):809-15. PubMed ID: 11820032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.
    Tan HK; James PD; Wong F
    Dig Dis Sci; 2016 Oct; 61(10):3084-3092. PubMed ID: 27048451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of ascites in children.
    Lane ER; Hsu EK; Murray KF
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1281-92. PubMed ID: 26325252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Current concepts in the management of refractory cirrhotic ascites.
    Oguntona SA; Alebiosu CO
    Niger J Med; 2006; 15(3):197-202. PubMed ID: 17111742
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.